Related Experiment Video
Updated: Jun 4, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Psychopharmacology of depression in children and adolescents
Susan M Smiga1, Glen R Elliott
1Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA. susan.m.smiga@dartmouth.edu
Abstract:
Although much debate continues about the prevalence of depressive disorders in prepubertal children, depression clearly is common in adolescents, increasing rapidly throughout the teen years. All physicians who work with young patients must to be able to recognize and treat these disorders. This article provides a brief overview of depressive disorders in children and adolescence, including their clinical presentation, prevalence, etiology, course, and prognosis. Psychopharmacological treatment options are reviewed in detail, including practical information for medication management including patient education, making the decision to treat with medication, selection of specific medications, strategies for nonresponsive patients, and decisions about stopping medication.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
